Biperiden lactate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for biperiden lactate and what is the scope of patent protection?
Biperiden lactate
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for biperiden lactate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| Clinical Trials: | 1 |
| Patent Applications: | 380 |
| DailyMed Link: | biperiden lactate at DailyMed |
Recent Clinical Trials for biperiden lactate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Sao Paulo | Phase 3 |
| Cristália Produtos Químicos Farmacêuticos Ltda. | Phase 3 |
| Federal University of São Paulo | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for biperiden lactate
US Patents and Regulatory Information for biperiden lactate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | AKINETON | biperiden lactate | INJECTABLE;INJECTION | 012418-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
